*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p><strong>Teriflunomide</strong> (CAS 146282-25-1) is an active metabolite of leflunomide, synthesized via catalytic hydrolysis. Its molecular formula is C12H9F3N2O2. This immunomodulator serves as a key API in neurology.</p>
<h3>Application</h3>
<ul>
<li>Multiple Sclerosis (MS) treatment to reduce relapse frequency.</li>
<li>Pharmaceutical manufacturing for oral tablet formulations.</li>
<li>Rheumatology research for autoimmune disorder mechanisms.</li>
</ul>
<h3>Precautions</h3>
<p>Contraindicated in pregnancy due to teratogenicity; requires strict contraception protocols. Store in cool, dry conditions below 25°C away from direct light. Personnel must wear PPE during handling to prevent inhalation or skin contact.</p>